Home › Atopic Dermatitis (Eczema) › Texas › Arlington
Atopic Dermatitis (Eczema) clinical trials in Arlington, TX
4 studies for Atopic Dermatitis (Eczema) are looking for participants at sites in and around Arlington (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Platform Study to Evaluate the Efficacy and Safety of Investigational Compound(s) in Patients With Moderate to Severe Atopic Dermatitis
RecruitingPhase 2
- Novartis Investigative Site, Arlington
Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis
RecruitingPhase 2
- Enveda Investigative Site, Arlington
A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
RecruitingPhase 3
- Arlington Research Center, Inc /ID# 266330, Arlington
- Prime Clinical Research - Mansfield - East Broad Street /ID# 268042, Mansfield · 12 mi away
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
RecruitingPhase 3
- Arlington Research Center, Inc /ID# 263665, Arlington
Atopic Dermatitis (Eczema) trials in other cities
- New York City, NY13 studies
- Los Angeles, CA11 studies
- Washington, DC11 studies
- San Diego, CA10 studies
- San Antonio, TX10 studies
- Miami, FL9 studies
- Birmingham, AL9 studies
- Troy, MI8 studies
- Dallas, TX8 studies
- Huntington Beach, CA8 studies
- Sacramento, CA8 studies
- Tampa, FL7 studies
Other studies in Arlington
- Steatotic Liver Disease6 studies
- Crohn's Disease5 studies
- Lupus4 studies
- Chronic Kidney Disease4 studies
- Non-Small Cell Lung Cancer4 studies
- Sjogren's Syndrome4 studies
- Ulcerative Colitis4 studies
- Psoriatic Arthritis4 studies
- Rheumatoid Arthritis4 studies
- High Blood Pressure3 studies
- Overactive Bladder3 studies
- Breast Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.